EBITDA Margin: Earnings before interest, taxes, depreciation and amortization as a portion of total revenue. Calculated as: EBITDA / Total Revenues
Redhill Biopharma Ltd. (RDHL) had EBITDA Margin of -2633.92% for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$0.29M |
|
$-0.43M |
|
-- |
|
$0.29M |
|
$8.23M |
|
$-7.94M |
|
$-0.14M |
|
$-8.08M |
|
$-8.08M |
|
$-8.08M |
|
$-8.08M |
|
$-0.43M |
|
$-8.08M |
|
$-7.94M |
|
$-7.53M |
|
3.16M |
|
3.16M |
|
$0.00 |
|
$0.00 |
|
| Balance Sheet Financials | |
$6.53M |
|
$0.05M |
|
$18.82M |
|
$25.34M |
|
$19.22M |
|
-- |
|
$1.86M |
|
$21.08M |
|
$4.27M |
|
$-1.02M |
|
$4.27M |
|
5.09M |
|
| Cash Flow Statement Financials | |
$-9.65M |
|
$1.69M |
|
$7.32M |
|
$4.62M |
|
$3.97M |
|
$-0.65M |
|
$0.46M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.34 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-2776.92% |
|
-2776.92% |
|
|
EBITDA Margin |
-2633.92% |
-2825.18% |
|
-150.00% |
|
$-9.66M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
3.62 |
|
100.82 |
|
-189.32% |
|
789.83% |
|
-31.88% |
|
-189.32% |
|
$0.84 |
|
$-3.06 |
|
$-3.06 |
|